Drug-drug interactions in patients admitted to the hospital: prevalence and associated adverse drug events
European Journal of Clinical Pharmacology · 2026-12 · 82 (12)
DOI: 10.1007/s00228-026-04224-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 10.11.2026. Verfasst von Zuzana Juhásová und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy in Hradec Králové, Department of Social and Clinical Pharmacy, Charles University, Hradec Králové, Czech Republic. ocovskaz@faf.c…. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Hospitalization. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Charles University, IOCB Foundation, Martina Roeselová Memorial Fellowship.
Abstract (Originalsprache)
PURPOSE: Drug-drug interactions (DDIs) are increasingly common in aging populations. Although many studies address potential DDIs, few explore clinically manifested DDIs. The objective of this study was to examine the prevalence and characteristics of potential and clinically manifested DDIs in patients admitted to the hospital. METHODS: This cross-sectional observational study analyzed consecutive hospital admissions following an emergency department visit in 2018. The cases with at least two medications prior to admission in the medication history were included. Medication history prior to admission was screened for potential DDIs using Micromedex, Uptodate and Stockley drug interaction databases. Potential DDIs were defined as those detected by at least one drug interaction database with moderate or greater severity. Clinically manifested DDIs were defined as those linked to adverse drug events. RESULTS: Of 1,252 eligible patients, 968 met the inclusion criteria (median age: 75, median number of medications: 7). A total of 7801 potential DDIs were identified in 89% (95% CI: 88-91) of patients. The total number of clinically manifested DDIs was 116 (1.5% of potential DDIs). Of these, 97 were involved in adverse drug events that contributed to hospital admission of 6% (95% CI: 4-7) of patients. These clinically manifested DDIs primarily involved bleeding, with antithrombotic agents being the most common culprits. CONCLUSION: Potential DDIs were highly prevalent among acutely admitted patients, while clinically manifested DDIs were less frequent. Nevertheless, the proportion of clinically manifested DDIs that contributed to hospital admissions was higher than previously reported, highlighting the increasing importance of this issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy in Hradec Králové, Department of Social and Clinical Pharmacy, Charles University, Hradec Králové, Czech Republic. ocovskaz@faf.cuni.cz.
- Faculty of Pharmacy in Hradec Králové, Department of Social and Clinical Pharmacy, Charles University, Hradec Králové, Czech Republic.
- Department of Clinical Pharmacy, University Hospital Hradec Králové, Hospital Pharmacy, Hradec Králové, Czech Republic.
Förderung
- Charles University
- IOCB Foundation, Martina Roeselová Memorial Fellowship
Zitieren
APA
Juhásová, Z., Maříková, M., & Vlček, J. (2026). Drug-drug interactions in patients admitted to the hospital: prevalence and associated adverse drug events. European Journal of Clinical Pharmacology, 82(12). https://doi.org/10.1007/s00228-026-04224-2
Vancouver
Juhásová Z, Maříková M, Vlček J. Drug-drug interactions in patients admitted to the hospital: prevalence and associated adverse drug events. European Journal of Clinical Pharmacology. 2026;82(12). doi:10.1007/s00228-026-04224-2
BibTeX
@article{Juhsov2026,
author = {Juhásová, Zuzana and Maříková, Martina and Vlček, Jiří},
title = {Drug-drug interactions in patients admitted to the hospital: prevalence and associated adverse drug events},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {12},
doi = {10.1007/s00228-026-04224-2}
}
EUVIMED